Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel diseaseJan Wehkamp, Eduard F. Stange, Klaus Fellermann et al.|European Journal of Gastroenterology & Hepatology|2002Cited by 200
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatmentTorsten Schröder, Jürgen Büning, Klaus J. Schmidt et al.|European Journal of Gastroenterology & Hepatology|2015Cited by 36
Does Etiology of Acute Pancreatitis Matter? A Review of 391 Consecutive EpisodesGünther Weitz, Klaus Fellermann, Klaus J. Schmidt et al.|PubMed|2015Cited by 33
Detrimental effect of high volume fluid administration in acute pancreatitis – A retrospective analysis of 391 patientsGünther Weitz, Klaus Fellermann, Julia Woitalla et al.|Pancreatology|2014Cited by 28
Crohns Targeted Therapy: Myth or Real Goal?Klaus J. Schmidt, Klaus Fellermann, Jürgen Büning et al.|Current Drug Discovery Technologies|2009Cited by 15